Skip to main content

Table 3 Probability of neurotoxicity of MCS-driven cefepime dosing recommendation in five kidney replacement therapies

From: Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy

 

KRT setting

PD target†

MCS-driven Cefepime dosing recommendation

Probability of total concentration above neurotoxicity threshold at the end of each day during 1 week of therapy£

Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

1

4-hour HD on Mon-Wed-Fri

60% fT > MIC

2 g LD, 1 g q24h post-HD

58.5%

10.0%

41.9%

10.7%

41.2%

51.9%

16.6%

60% fT > MICx4

3 g LD, 2 g q12h post-HD

98.2%

84.7%

98.3%

85.1%

98.3%

98.4%

85.5%

2

4-hour HD daily

60% fT > MIC

2 g LD, 1 g q24h post-HD

1.9%

1.1%

1.1%

1.2%

1.3%

1.5%

1.5%

60% fT > MICx4

3 g LD, 2 g q12h post-HD

62.9%

70.0%

70.6%

70.6%

70.6%

70.6%

70.6%

3

Sequential 4-hour HD & 20-hour UF

60% fT > MIC

2 g LD, 1 g q24h post-HD

0.7%

0.3%

0.3%

0.3%

0.4%

0.4%

0.4%

60% fT > MICx4

3 g LD, 2 g q12h post-HD

58.4%

65.7%

66.2%

66.3%

66.3%

66.3%

66.3%

4

Early 9-hour

PIKRT€

daily

60% fT > MIC

1 g q12h

58.1%

74.7%

77.4%

78.0%

78.2%

78.2%

78.2%

60% fT > MICx4

2 g LD, 1 g q6h

99.9%

99.9%

99.9%

99.9%

99.9%

99.9%

99.9%

Late 9-hour

PIKRT€

daily

60% fT > MIC

1 g q12h

1.6%

16.4%

23.2%

25.0%

25.6%

25.7%

25.8%

60% fT > MICx4

2 g LD, 1 g q6h

81.6%

80.3%

80.3%

81.3%

80.3%

80.3%

80.3%

5

Extended PIKRT

daily

60% fT > MIC

1 g q12h

2.1%

11.8%

16.4%

17.7%

18.1%

18.3%

18.4%

60% fT > MICx4

2 g q8h

62.2%

67.9%

68.2%

68.2%

68.2%

68.2%

68.2%

  1. KRT: kidney replacement therapy; PD: pharmacodynamic; MCS: Monte Carlo simulation; HD: Hemodialysis at dialysate flow rate (Qd) 300 ml/min; UF: Ultrafiltration at ultrafiltration flow rate of 5 ml/min; PIKRT: Prolonged intermittent kidney replacement therapy (9-hour PIKRT runs at Qd 100 ml/minl and extended PIKRT runs at Qd 50 ml/min for 24 h); LD: loading dose
  2. †60% fT> MIC or 60% fT> MICx4 denotes at least 60% of time during each day of one week of antibiotic therapy that the free plasma drug concentration was greater than the target minimum inhibitory concentration (MIC) or four time of the target MIC of 8 mg/L (susceptibility breakpoint MIC for P. aeruginosa)
  3. £This indicates the percentage of 5000 simulated patients that were at or above the suggested cefepime neurotoxicity threshold (i.e. total plasma concentration ≥ 20 mg/L) at the end of each day during 1 week of therapy
  4. € EARLY PIKRT is where the initial cefepime dose is infused at the beginning of 9-hour PIKRT and late PIKRT where the initial cefepime dose is given 15 h prior to 9-hour PIKRT